Defibrio
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1167 Massachusetts Ave, Arlington, Massa...Website
www.defibrio.comRevenue
<$5 MillionIndustry
About Defibrio
Defibrio Org Chart
Is Defibrio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Defibrio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Defibrio launches new products
Click to see if Defibrio had a recent Job posting/layoffs
Check out if Defibrio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Defibrio
Funding: Get notified immidiatlly once Defibrio has new funding data
Defibrio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Defibrio recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Defibrio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Defibrio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Defibrio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Defibrio.
Defibrio Tech Stack
A closer look at the technologies used by Defibrio
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Defibrio
Defibrio is the creator of the world's first smartphone-powered AED, designed to make life-saving care affordable and accessible. Their innovative device leverages smartphone technology to provide a lightweight, easy-to-use defibrillator that can significantly increase survival rates during sudden cardiac arrests. Targeting families and individuals... Read More